Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands'. Together they form a unique fingerprint.